INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined garlic. Clear

Pooled results from many studies on one question.

7 studies

2022 / Random effects network meta-analysis of randomized trials

Bergamot and red yeast rice were the most effective nutraceuticals for reducing LDL-C and total cholesterol in a network meta-analysis of 131 trials.

A network meta-analysis assessed the comparative efficacy of various lipid-lowering nutraceuticals across 131 trials with 13,062 participants. Except for policosanols, all evaluated nutraceuticals reduced LDL-C (-1.21 to -0.17 mmol/l) and TC (-1.75 to -0.18 mmol/l) compared with placebo or no intervention. Bergamot and red yeast rice were the most effective for lowering LDL-C (-1.21 mmol/l [-46.8 mg/dl] and -0.94 mmol/l [-36.4 mg/dl], respectively) and TC. The authors noted that evidence for bergamot was based on a relatively small study group and requires further investigation.

Osadnik T, Goławski M, Lewandowski P, et al. Pharmacol Res, 2022. PMID 35988871

2019 / Systematic review and meta-analysis

In patients with diabetes, garlic intake significantly improved lipid parameters, fasting blood sugar, and HbA1C compared to placebo.

A systematic review and meta-analysis of 33 studies evaluated the effects of garlic compared with placebo in 1,273 individuals with diabetes. Garlic was associated with significant decreases in total cholesterol by 16.87 mg/dl (95% CI, -21.01 to -12.73; P=0.001), LDL by 9.65 mg/dl (95% CI, -15.07 to -4.23; P=0.001), triglycerides by 12.44 mg/dl (95% CI, -18.19 to -6.69; P=0.001), fasting blood sugar by 10.90 mg/dl (95% CI, -16.40 to -5.40; P=0.001), and HbA1C by 0.60 mg/dl (95% CI, -0.98 to -0.22; P=0.001). Serum HDL significantly increased by 3.19 mg/dl (95% CI, 1.85 to 4.53; P=0.001).

Shabani E, Sayemiri K, Mohammadpour M Prim Care Diabetes, 2019. PMID 30049636

2018 / Systematic review

Evidence for superfood effects on metabolic syndrome risk factors remains limited

A systematic review evaluated 113 controlled human intervention trials testing 17 putative superfoods on risk markers for metabolic syndrome. Studied foods included garlic (21 trials), flaxseed (22 trials), cocoa (16 trials), blueberries (8 trials), and strawberries (7 trials). The authors found limited overall evidence for beneficial impacts on waist circumference, BMI, blood pressure, blood glucose, or lipids, citing inconsistent findings across trials and a small number of studies for many evaluated foods.

van den Driessche JJ, Plat J, Mensink RP Food Funct, 2018. PMID 29557436

2016 / Updated meta-analysis and review of randomized controlled trials

Garlic preparations reduced systolic and diastolic blood pressure, with larger reductions seen in hypertensive individuals.

Researchers updated a meta-analysis of randomized controlled trials evaluating the effect of garlic preparations on blood pressure and reviewed its effects on cholesterol and immunity. In 20 trials with 970 participants, garlic decreased systolic blood pressure by a mean ± SE of 5.1 ± 2.2 mm Hg (P < 0.001) and diastolic blood pressure by 2.5 ± 1.6 mm Hg (P < 0.002) compared with placebo. In trials of hypertensive subjects, reductions were larger: 8.7 ± 2.2 mm Hg for SBP (P < 0.001; n = 10) and 6.1 ± 1.3 mm Hg for DBP (P < 0.001; n = 6). A previously published meta-analysis cited in the review noted a 10% reduction in total and LDL cholesterol when taken for >2 months by individuals with slightly elevated levels, and clinical trials showed reductions in upper respiratory infections.

Ried K J Nutr, 2016. PMID 26764326

2015 / Meta-analysis of randomized controlled trials

Garlic supplementation lowered systolic and diastolic blood pressure in hypertensive patients.

A meta-analysis evaluated 7 randomized placebo-controlled trials investigating garlic for blood pressure management in hypertensive patients. Compared to placebo, garlic significantly decreased systolic blood pressure (WMD: -6.71 mmHg; 95% CI: -12.44 to -0.99; P = 0.02) and diastolic blood pressure (WMD: -4.79 mmHg; 95% CI: -6.60 to -2.99; P < 0.00001). No serious adverse events were documented across the trials.

Xiong XJ, Wang PQ, Li SJ, et al. Phytomedicine, 2015. PMID 25837272

2014 / Meta-analysis of randomized controlled clinical trials

Garlic powder supplementation significantly reduced total cholesterol, LDL-C, fasting blood glucose, and blood pressure in randomized clinical trials.

A meta-analysis evaluated randomized controlled trials investigating the effects of garlic powder intake on cardiovascular disease risk factors. Garlic powder intake significantly reduced total cholesterol by -0.41 mmol/L (-15.83 mg/dL) and LDL-C by -0.21 mmol/L (-8.11 mg/dL). It also lowered fasting blood glucose by -0.96 mmol/L (-17.30 mg/dL), systolic blood pressure by -4.34 mmHg, and diastolic blood pressure by -2.36 mmHg.

Kwak JS, Kim JY, Paek JE, et al. Nutr Res Pract, 2014. PMID 25489404

2013 / Meta-analysis of trials

Garlic preparations reduced total and LDL cholesterol in individuals with elevated levels.

A meta-analysis of 39 primary trials investigated the lipid effects of garlic preparations. In individuals with total cholesterol above 200 mg/dL, treatment for more than 2 months reduced total cholesterol by 17 ± 6 mg/dL and LDL cholesterol by 9 ± 6 mg/dL. HDL cholesterol rose only slightly, whereas triglycerides showed no significant alteration.

Ried K, Toben C, Fakler P Nutr Rev, 2013. PMID 23590705